December 2013
·
15 Reads
Nouvelles Dermatologiques
Imatinib is a tyrosinekinase inhibitor used in the treatment of chronic myeloid leukemia and gastrointestinal stromal tumors (GIST). Cutaneous side effects with this treatment are common but lichenoid drug eruption is exceptional. We report a new case.